Stem and progenitor cells in the pathogenesis and treatment of digestive diseases

3Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The global epidemic of chronic degenerative diseases expands rapidly. The pathogenesis of these noncommunicable disorders revolves around innate immunity, microbiome, and stem cell alterations. Understanding the mechanisms behind stem cell biology and their regulatory pathways is a key to understanding the origin of human disease. Stem cells are involved in tissue and organ damage and regeneration. The evidence is mounting that not only eukaryotic cells but also gut microbiota may release extracellular microvesicles that are absorbed from the gut into the portal and systemic circulation. Linking the fields of stem cells, innate immunity and microbiome research opens up new avenues to develop novel diagnostic (e.g., biomarkers), therapeutic (e.g., microbiome modulation, stem cell-based medicines), and prognostic (personalized diets) tools. In this chapter, we present the short overview of various stem and progenitor cells of adult tissues circulating in peripheral blood and their role in the pathogenesis and treatment of digestive diseases. We also briefly discuss the role of host-stem cell-microbial interactions as a new frontier of research in gastroenterology.

Cite

CITATION STYLE

APA

Marlicz, W., Łoniewski, I., & Skonieczna-Żydecka, K. (2019). Stem and progenitor cells in the pathogenesis and treatment of digestive diseases. In Advances in Experimental Medicine and Biology (Vol. 1201, pp. 125–157). Springer. https://doi.org/10.1007/978-3-030-31206-0_7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free